When conducting a double-blind clinical trial to evaluate a new treatment, the investigator is faced with the problem of what to give the control group. If there is no existing acceptable and beneficial treatment against which the new treatment can ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles